German deeptech startup Vara has developed an AI-powered platform for radiologists that combines the strengths of humans and of AI to make both better. Today the company supplies AI technology to over 20% of German breast cancer screening units and in 2022 it is now getting serious about internationalization. To kick off this expansion Vara has joined forces with Argentinian healthtech company…
Whiterabbit, an AI technology company focused on early breast cancer detection, has announced a new partnership with Solis Mammography, one of the largest independent providers of breast health and diagnostic services in the United States. After pilots in multiple markets demonstrated improvement in screening mammography bookings and patient compliance, the company implemented the ACT product at more than 70 centers. Through this…
Therapixel has received a second 510(k) clearance from the U.S. Food and Drug Administration (FDA) for MammoScreen, AI-based software assisting radiologists in breast cancer screening. This new clearance expands the use of Mammoscreen to Digital Breast Tomosynthesis (3D Mammography). Therapixel is a French company specialized in the design and commercialization of AI-powered medical imaging software, with the goal of delivering pertinent information…
Medical software provider Novarad has formed a strategic partnership with Ikonopedia, a structured breast reporting and MQSA management system designed to improve reporting efficiency and optimize facility operations. Ikonopedia’s next-generation breast reporting and tracking system for mammography will integrate with Novarad’s NovaMG PRO mammography platform. By combining leading-edge technologies with innovative software applications to connect patient care, Novarad’s complete care platform can…
Aidoc, a leading provider of AI for medical imaging, and ScreenPoint Medical, a leader of deep learning AI for 2D and 3D mammography have announced a collaboration which will incorporate ScreenPoint’s capabilities into Aidoc’s platform. Breast imaging specialists will now be able to benefit from one point of access to AI within the existing physician workflow, providing for early detection and diagnosis of…
Delphinus has announced that the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) of its SoftVue 3D Whole Breast Ultrasound Tomography System for use as an adjunct to digital mammography in the screening of asymptomatic women with dense breast tissue. Clinical evidence has demonstrated that SoftVue enhances dense breast screening and identifies up to 20% more cancers with greater accuracy…
Brilliantly and Mammogen, two female-led women’s health companies centered around breakthrough technologies designed to solve unmet clinical needs associated with breast cancer, have announce a new partnership with the goal to improve quality of care for the breast cancer community, both inside and outside of the physician’s office. The collaboration, which will equip breast cancer previvors and survivors with the tools they…
Bloomer Tech is a venture-backed startup focused on solutions for cardiovascular disease and stroke in women, ushering the new age of equitable personalized diagnostics. Its founder, Alicia Chong Rodriguez, recently spoke at TED sharing her company’s story and mission of transforming everyday bras into smart medical devices that gather often-overlooked data on heart disease in women, a frequently misdiagnosed and under-researched killer.…
